Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Preterm Neonates With Non-Invasive Respiratory Support
NCT ID: NCT06642285
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2024-08-01
2025-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Facilitated Tucking Position During Endotracheal Suctioning
NCT06428916
Cardiorespiratory Effects of Nasal High Frequency Ventilation in Neonates
NCT05706428
Ventilatory Management of the Preterm Neonate in the Delivery Room
NCT01255826
Nasal High Frequency in Preterm Neonates
NCT06687083
High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure for Respiratory Support of Preterm Neonates
NCT04238273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Control Group: Consisted of 30 premature neonates who will receive conventional hospital care with no additional interventions.
Study Group: Consisted of 30 premature neonates who will receive 6 evidence-based practices on the prevention of nasal pressure injuries as follows:
* Use an appropriately sized nasal interface device.
* The Use of Skin Barrier Products between nasal skin and nasal interface device
* Visually examining the preterm newborn every hour to ensure appropriate nasal interface position
* Once every 12-hour shift, the protective barrier and nasal device are briefly removed to allow for a full nasal skin examination
* Follow developmental care principles by repositioning the infant every three to four hours.
* Pain scores should be taken at least every three to four hours.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
: it will include thirty premature neonates who will receive the usual hospital care in accordance with hospital protocols, without any extra procedures or therapies.
No interventions assigned to this group
Bundle group
: it will include thirty premature neonates who will receive evidence-based guidelines on the prevention of nasal pressure injuries in form of a care bundle from the first day of providing NIRS till weaning.
Non Invasive Respiratory Support bundle
premature neonates who will receive evidence-based guidelines for prevention of nasal pressure injuries associated with non invasive respiratory support till weaning
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non Invasive Respiratory Support bundle
premature neonates who will receive evidence-based guidelines for prevention of nasal pressure injuries associated with non invasive respiratory support till weaning
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* whose gestational ages ranges between 30 and 37 weeks, and both genders
Exclusion Criteria
* have prior nasal trauma caused by tracheal intubation
* or Infants exhibiting evidence of nasal damage during the NIRS procedure,
* have upper respiratory abnormalities.
* preterm neonates who have undergone any type of surgery and had life-threatening congenital abnormalities.
30 Weeks
37 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kafrelsheikh University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eman Wardany Abdelaal Mohamed
assistant professor of pediatric nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eman W Wardany, ass. professor
Role: PRINCIPAL_INVESTIGATOR
pediatric nursing department, faculty of nursing kafrelsheikh univeristy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kafrelsheikh University
Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kafrelsheikh University W Kafr Ash Shaykh, Ass. Professor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KafrelsheikhU4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.